15 Virus 3 Flashcards

1
Q

types of immunity required

A

sterile immunity
T-cell or humoral
systemic or mucosal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

how is sterile immunity achieved

A

it is difficult to achieve

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what is most effective in T-cell or humoral

A

both arms most effective

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what does systemic or mucosal need

A
class of Ig required
mucosal = IgA (short lived)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what do the most effective vaccines induce

A

do not induce sterile immunity - rather it builds up an amnestic response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what is the problem with HIV and HCV

A

Problematic for hypervariable persistent viral infections

as sterile immunity not induced

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

live viral vaccines effect

A

related non-pathogenic virus that gives cross-protection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

example of live attenuated virus

A

cow pox protects against small pox

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

live viruses

A
  • Attenuated

- Reduce pathogenicity of a virus by passage in cell culture or non-human host

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

where is pathogenic virus located

A

from a patient and grown in human cultured cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what is used to infect monkey cells

A

Cultured virus is used to infect monkey cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what allows a virus to grow in monkey cells

A

Virus acquires many mutations that allow it to grow well in monkey cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Advantages of live vaccines

A
  • development and production straightforward
  • low cost
  • cell-mediated (and mucosal) immunity stimulated
  • can be highly immunogenic, giving long lasting protective immunity
  • fewer inoculations that other systems required
  • live microorganisms provide continual antigenic stimulation giving sufficient time for memory cell production
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Disadvantages of live vaccines

A
  • many cause (generally mild) disease
  • reversion to virulence may occur
  • virus shedding – potentially infect others
  • potential harm to immunocompromised individuals
  • unstable – requires continuous refrigeration
  • less safe than inactivated vaccines
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

why are recombinant proteins safe

A

No infectious agent - safe

Antigenicity of prokaryotic-expressed proteins sometimes poor - yeast or insect cell expression better

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Recombinant surface antigen disadvantages

A

> Poorly immunogenic
Requires multiple boosts
Expensive
Problem for developing countries

17
Q

Recombinant surface antigen advantages

A

> Safe

> Also protects against Hepatitis delta virus

18
Q

what does the recombinant protein - Human Papilloma Virus cause

A

genital warts associated with cancer
Squamous cell carcinoma
Malignancy in genital tract

19
Q

Inactivated (killed) viruses

A
  • Chemical treatment, safe, poor antigenicity, humoral immunity only
  • Side effects - inflammatory responses, Purified subunits overcome this
  • Mainly induced circulatory IgG
  • Continual shedding of virus from vaccines
  • Requires repeated boosting
20
Q

what is Hepatitis A vaccine like

A

Inactivated cell culture-grown virus

21
Q

rabies injections

A

Pre and post-contact vaccination by IM injection

22
Q

rabies vaccine

A

human diploid cell vaccine

23
Q

Influenza vaccine like

A

Inactivated viral vaccine “split” or purified H and N from virus in hen eggs - allergy risk (rare)

24
Q

what does influenza protect against

A

Protects against 2 ‘Flu A strains plus 2 ‘Flu B

25
Q

Enhancing immunogenicity

A

Adjuvants improve immune response potency

26
Q

what are immunogenicity incorporated in

A

several human vaccines in the form of particulate aluminium salts, such as Al(OH)3 and AlPO4

27
Q

examples of licensed adujvants

A

MF59
AS03
Virosomes
AS04

28
Q

MF59

A

Oil in water adjuvant effect in the influenza vaccine, but not when used with HSV-2 Glycoprotein

29
Q

AS03

A

contains α-tocopherol, squalene and polysorbate 80 in an oil-in-water emulsion, used in pandemic influenza vaccine

30
Q

Virosomes

A

Phospholipids that reconstitute influenza virosomes, used in the hepatitis A vaccine

31
Q

AS04

A

Monophosphoryl lipid A (MPL) and aluminium hydroxide, approved for use in HBV (Fendrix) and HPV (Cervarix) vaccines

32
Q

Safety concerns

A

Pandemic influenza vaccine associated with sudden onset narcolepsy in children

33
Q

DNA vaccines

A

Inject DNA containing antigenic coding region plus promoters

- Site of injection, Persistance, Presentation pathway, Safety

34
Q

Live vector vaccines

A

Use of a non-pathogenic virus or bacterium to elicit an immune response to target virus

35
Q

how are live vector vaccines produced

A

genetic modification to express foreign viral genes